Table 2 Per protocol response rates and Lund Efficacy Index (LUNDEX) adjusted response rates at follow-up times grouped according to concomitant methotrexate treatment

	MTX			No MTX
Follow-up month	3	6	12	3	6	12
Number at observation for VAS responses	n = 108	n = 87	n = 79	n = 71	n = 56	n = 31
VASglobal 50% improvement	48	53	41	48	50	45
VASpain 50% improvement	49	57	42	44	52	39
Number at observation for EULAR responses	n = 104	n = 82	n = 74	n = 67	n = 54	n = 27
EULAR overall	78	76	69	75	81	67
EULAR good	51	60	54	55	59	52
LUNDEX adjusted treatment responses
LUNDEX_VASglobal50	46	47	33	43	41	31
LUNDEX_VASpain50	47	51	34	40	42	25
LUNDEX_EULARoverall	74	68	55	68	67	45
LUNDEX_EULARgood	48	53	43	50	48	35

Values are shown as percentages of patients fulfilling the particular response criteria at follow-up times 3, 6, and 12 months respectively. The per protocol number of patients evaluated for either VAS or EULAR response at each timepoint is listed in the table.
EULAR, European league Against Rheumatism; MTX, methotrexate, VAS, visual analogue scale.